Rights to Publish Sample Clauses

Rights to Publish. UWMRF (on behalf of itself, the University and the Inventor) and Company reserves their rights to release or publish, either written or orally, the results of research related to the Licensed Subject Matter, to the scientific and business community in scientific journals or at any industry, investment, field, trade, business, scientific or technical conference, seminar, symposia or similar event, so long as such publication does not conflict with the other provisions of this Article 12. Without limiting the generality of the foregoing, Company shall be entitled to present, publish and release the results of its scientific work and development efforts without notification to or consent from UWMRF. In the event UWMRF or University (or any of their respective faculty, employee(s) or students) desires to publish the results of research related to the Licensed Subject Matter, such party shall give Company no less than sixty (60) days prior to the submission for publication a copy of the proposed publication (or an outline of such oral disclosure) to review the proposed publication and provide UWMRF with its comments and suggested changes. UWMRF shall take such comments and suggested changes reasonably into account. Within this sixty (60) day period the Company may request UWMRF, in writing, to delay such submission for publication or oral disclosure for a maximum of an additional thirty (30) days in order to protect the potential patentability of any invention described therein, and UWMRF shall comply with any such request so long as it is reasonable and cooperate with Company towards that end. Such delay must not, however, be imposed on the filing of any student thesis or dissertation by way of this Article 12.5. In no event shall the public release of any proposed publication or oral disclosure be delayed more than ninety (90) days from the date of its submission to Company. Upon the expiration of such sixty (60) day period from receipt by Company of such proposed publication, then UWMRF shall be free to proceed with the written publication or the oral presentation, unless Company has requested the delay described above.
AutoNDA by SimpleDocs
Rights to Publish. At the University’s request, inventors shall delay the publication or public disclosure of any descriptions of technology for a brief period of time to permit the registration, application for, and protection of the intellectual property UNIVERSITY OF MINNESOTA BOARD OF REGENTS POLICY Academic COMMERCIALIZATION OF INTELLECTUAL PROPERTY RIGHTS Adopted: December 14, 2007 Amended: December 10, 2010, February 14, 2014, June 12, 2015 Page 4 of 6 rights in the technology. Subd. 6.
Rights to Publish. UWMRF (on behalf of itself, the University and the Inventor) and COMPANY reserves their rights to release or publish, either written or orally, the results of research related to the
Rights to Publish. During the term of this Employment Agreement and thereafter, Employee shall not produce for publication, circulation or production any movies or writing of any kind, including but not limited to articles, books, manuscripts and screenplays about, concerning, discussing, or mentioning Jxxx X. Xxxxxx, or any person related to Jxxx X. Xxxxxx by blood or marriage whether such related person is now or at a later date deceased. Further, Employee shall not disclose any information to any party, or consult with any person or entity engaged in or making any efforts to publish, circulate or produce any writing, movie or television program of any kind whatsoever including but not limited to an article, book, manuscript, or screenplay concerning Jxxx X. Xxxxxx, or any person related to Jxxx X. Xxxxxx by blood or marriage whether such related person is now or at a later date deceased.
Rights to Publish. During the term of this Employment Agreement and thereafter, Employee shall not produce for publication, circulation or production any movies or writing of any kind, including but not limited to articles, books, manuscripts and playwrights about, concerning, discussing, or mentioning Jack Xxxxxx, xx any person related to Jack Xxxxxx xx blood or marriage whether such related person is now or at a later date is deceased. Further, Employee shall not disclose any information to any party, or consult with any person or entity engaged in or making any efforts to publish, circulate or produce any writing, movie or television program of any kind whatsoever including but not limited to an article, book, manuscript, or playwright concerning Jack Xxxxxx, xx any person related to Jack Xxxxxx xx blood or marriage whether such related person is now or at a later date deceased.
Rights to Publish. Company shall have the right to publish or publicly present Clinical Data or Sample Analysis Results (other than Clinical Data within Gilead Project IP) at any time; provided, however, that any such publication or presentation by or on behalf of Company shall be made solely in accordance with the provisions of Section 10.2.2. Gilead shall have the right to publish or publicly present Clinical Data or Sample Analysis Results (other than Clinical Data within Company Project IP) at any time after the earlier of (a) Company’s first publication or public presentation of Clinical Data or Sample Analysis Results and (b) the date that is [***] months after Company first provides to Gilead a draft of the final study report for the Gilead Arm pursuant to Section 4.1.4(c); provided, however, that Gilead shall have the right to publish or publicly present any Clinical Data within Gilead Project IP at any time; and provided, further, that any such publication or presentation by or on behalf of Gilead shall be made solely in accordance with the provisions of Section 10.2.2. Notwithstanding the foregoing, (i) Company shall have the right to disclose or present any Clinical Data or Sample Analysis Results (other than Clinical Data within Gilead Project IP), and (ii) Gilead shall have the right to disclose [***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. or present any Clinical Data or Sample Analysis Results (other than Clinical Data within Company Project IP), in each case ((i) and (ii)), at any time in connection with internal meetings of Company or Gilead, as applicable, or otherwise for internal development purposes so long as all persons receiving such Clinical Data or Sample Analysis Results are employees or contractors of Company or Gilead, as applicable, that are subject to obligations of confidentiality and non-use with respect to such Clinical Data or Sample Analysis Results that are substantially similar to the obligations of confidentiality and non-use of Company or Gilead, as applicable, under this ARTICLE 8 (provided that the duration of such obligations shall be commercially reasonable under the circumstances).
Rights to Publish. 5.1 The data and information accruing from this Agreement may be published by USM in accordance with USM Intellectual Property Policy respecting the same. The Company may be provided with a copy of any proposed publication at least twenty-one (21) days prior to submission for review of patentable items or items deemed confidential as defined in clause 6 herein. The purpose of this clause is to further protect the rights of USM and the Company in the protection of any contemplated publication concerning details of an invention or the Company’s Confidential Information as defined in the clause 6 herein If deemed reasonably necessary by USM and/or the Company to protect such interests, any contemplated publication concerning details of an invention, etc, may be withheld until a patent application is filed or other appropriate steps to protect the commercial value have been contemplated. Notwithstanding clause 5.2 above, in no event shall any publication be delayed exceeding twelve (12) months from the date the proposed publication is provided to the Company, but such publication shall not include the Company’s Confidential Information as reasonably determined by the Company and communicated to USM within the twenty-one (21) day review period referenced in clause 5.1 above.
AutoNDA by SimpleDocs
Rights to Publish. 1.1 The Proprietor hereby guarantees that it has full power and authority to enter into this Agreement and grants to the Publisher for the term of three (3) years from the date of publication the exclusive licence to translate, at its own expense, publish and sell the Work in book form in the Slovakian language subject to the following terms and conditions.
Rights to Publish. 5.1 The data and information accruing from this Agreement may be published by USM in accordance with USM Intellectual Property Policy respecting the same. The Company may be provided with a copy of any proposed publication at least twenty- one (21) days prior to submission for review of patentable items or items deemed confidential as defined in clause 6 herein. The purpose of this clause is to further protect the rights of USM and the Company in the protection of any contemplated publication concerning details of an invention or the Company’s Confidential Information as defined in the clause 6 herein

Related to Rights to Publish

  • Rights to Purchase There are no outstanding agreements, options, rights of first refusal, conditional sales agreements or other agreements or arrangements, whether oral or written, regarding the purchase and sale of the Property, or which otherwise affect any portion of or all the Property. The representation contained in this Section 5.21 shall be true at and as of Closing.

  • Rights to Work Product The Employee agrees that all work performed by the Employee pursuant hereto shall be the sole and exclusive property of the Company, in whatever stage of development or completion. With respect to any copyrightable works prepared in whole or in part by the Employee pursuant to this Agreement, including compilations of lists or data, the Employee agrees that all such works will be prepared as “work-for-hire” within the meaning of the Copyright Act of 1976, as amended (the “Act”), of which the Company shall be considered the “author” within the meaning of the Act. In the event (and to the extent) that such works or any part or element thereof is found as a matter of law not to be a “work-for-hire” within the meaning of the Act, the Employee hereby assigns to the Company the sole and exclusive right, title and interest in and to all such works, and all copies of any of them, without further consideration, and agrees, to the extent reasonable under the circumstances, to cooperate with the Company to register, and from time to time to enforce, all patents, copyrights and other rights and protections relating to such works in any and all countries. To that end, the Employee agrees to execute and deliver all documents requested by the Company in connection therewith, and the Employee hereby irrevocably designates and appoints the Company as the Employee’s agent and attorney-in-fact to act for and on behalf of the Employee and in the Employee’s stead to execute, register and file any such applications, and to do all other lawfully permitted acts to further the registration, protection and issuance of patents, copyrights or similar protections with the same legal force and effect as if executed by the Employee. The Company shall reimburse the Employee for all reasonable costs and expenses incurred by the Employee pursuant to this Section 11.

  • Reports to Partners (a) Within thirty (30) days of the date of Substantial Completion, the General Partner shall cause to be prepared and distributed to the Investment Partnership, a Credit Basis Worksheet for each building, and in the form specified by Boston Capital.

  • Rights to Information 2.1 为行使本协议下委托权利之目的,受托人有权要求丙方提供相关信息,查阅丙方相关资料,丙方应对此予以充分配合。 For the purpose of this Agreement, the Designee is entitled to request relevant information of Party C and inspect the materials of Party C. Party C shall provide appropriate assistance to the Designee for his/her work.

  • Rights to Intellectual Property This Data Agreement does not give Service Provider any rights, implied or otherwise, to CDI, data, content or intellectual property except as expressly stated in any underlying agreement between the parties. This includes but is not limited to the right to share, sell or trade CDI. The District acknowledges that this agreement does not convey any intellectual property right in any of Service Provider’s materials or content, including any revisions of derivative work or material. Service Provider-owned materials shall remain the property of the Service Provider. All rights, including copyright, trade secrets, patent and intellectual property rights shall remain the sole property of the Service Provider.

  • Registration Rights to Others If the Company shall at any time hereafter provide to any holder of any securities of the Company rights with respect to the registration of such securities under the Securities Act, such rights shall not be in conflict with or adversely affect any of the rights provided to the Holders in, or conflict (in a manner that adversely affects Holders) with any other provisions included in, this Agreement.

  • Rights to Payment Each right to payment and each instrument, document, chattel paper and other agreement constituting or evidencing Collateral or other collateral covered by the Security Documents is (or, in the case of all future Collateral or such other collateral, will be when arising or issued) the valid, genuine and legally enforceable obligation, subject to no defense, setoff or counterclaim, of the account debtor or other obligor named therein or in the Borrower's records pertaining thereto as being obligated to pay such obligation.

  • Reports to Board Custodian shall provide written reports notifying the Board of the placement of Assets with a particular Foreign Custodian and of any material change in a Series’ foreign custody arrangements. Such reports shall be provided to the Board quarterly, except as otherwise agreed by the Custodian and the Fund.

  • Contractual Rights to Benefits This Agreement establishes and vests in the Executive a contractual right to the benefits to which he is entitled hereunder. However, nothing herein contained shall require or be deemed to require, or prohibit or be deemed to prohibit, the Company to segregate, earmark, or otherwise set aside any funds or other assets, in trust or otherwise, to provide for any payments to be made or required hereunder.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!